VolitionRx Limited Deferred Revenue
VolitionRx Limited (VNRX) had Deferred Revenue of $177.58 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:DeferredRevenueCurrent · last filed 2026-08-13
- 2026-06-30: Deferred Revenue, Current $177.58K.
- 2026-03-31: Deferred Revenue, Current $353.85K.
- 2025-12-31: Deferred Revenue, Current $353.85K.
- 2025-09-30: Deferred Revenue, Current $354.00K.
| Period end | Deferred Revenue, Current | Deferred Revenue, Current as first filed |
|---|---|---|
| 2026-06-30 | $177.58K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $353.85K 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $353.85K 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $354.00K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $122.44K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $230.00K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $230.00K 10-K · filed 2026-03-31 | |
| 2024-09-30 | $22.89M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $22.94M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $23.00M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $106.60K 10-K · filed 2025-03-31 | $23.00M 10-K · filed 2024-03-25 |
| 2023-09-30 | $10.00M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $10.00M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $10.00M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $10.00M 10-K · filed 2024-03-25 | |
| 2022-09-30 | $10.00M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $10.00M 10-Q · filed 2022-08-10 | |
| 2021-12-31 | $12.51K 10-K · filed 2023-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |